BBS9 is required for primary cilium biogenesis across multiple cell types, with its loss abolishing or reducing ciliation in zebrafish Kupffer's vesicle, mouse IMCD3 cells, and patient-derived suture mesenchymal cells (PMID:22479622, PMID:29674126). Structurally, BBS9 is built from four domains, including an N-terminal seven-bladed β-propeller that mediates protein-protein interactions and a C-terminal half that dimerizes in solution, an interface implicated in assembly of the larger ciliary machinery (PMID:26085087). Disease-associated lesions act through two mechanisms: missense mutations such as G141R misfold the β-propeller, and a wild-type but not a missense-mutant BBS9 mRNA rescues the zebrafish ciliary phenotype, directly tying these mutations to loss of ciliary function (PMID:26085087, PMID:22479622). Beyond its requirement for ciliogenesis, BBS9 supports osteogenic differentiation of cranial suture mesenchymal cells, linking ciliary defects to craniosynostosis (PMID:29674126). The molecular partners of BBS9 within the ciliary trafficking machinery are not characterized in the available corpus.